U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06944873) titled 'Metabolic Reprogramming of Monocytes in Inflammatory Flares of Inflammatory Bowel Diseases' on Jan. 13.
Brief Summary: Inflammatory bowel diseases, Crohn's disease and haemorrhagic rectocolitis, are pathologies that progress in flare-ups, impacting on patients' quality of life and functional or even vital prognosis. These inflammatory diseases require the use of immunosuppressive and immunomodulatory treatments, the side-effects of which can be significant, and the limited number of which sometimes puts patients and practitioners in a therapeutic impasse from which surgery is the only way out. It is therefore important to be able t...